BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...administered repeatedly without puncturing the lung. Oncorus has been developing the product based on the Seneca Valley virus...
BioCentury | Jan 31, 2011
Strategy

Lysing what it sees

...Biotherapeutics Inc. JX-594 Recombinant vaccinia virus (TK-deletion plus GM-CSF) Liver cancer Ph II Neotropix Inc. NTX-010...
BioCentury | May 24, 2010
Clinical News

Seneca Valley Virus: Phase II started

...NTX-010 in 99 patients. Neotropix Inc. , Malvern, Pa. Product: Seneca Valley Virus ( NTX-010 ) (formerly SVV-001...
BioCentury | Nov 20, 2008
Tools & Techniques

Micromanaging oncolytic viruses

...administered. At the levels we are delivering, the main concern is clearly liver toxicity." Neotropix's NTX-010...
BioCentury | Nov 20, 2008
Tools & Techniques

Table 1. Oncolytic virus therapies

...modified to produce a toxic metabolite in tumor cells Brain cancer Phase I Neotropix Inc. NTX-010...
BioCentury | Oct 13, 2008
Clinical News

Seneca Valley Virus: Phase I expanded

...designation for neuroendocrine cancers. Neotropix Inc. , Malvern, Pa. Product: Seneca Valley Virus ( NTX-010 ) (formerly SVV-001...
BioCentury | Oct 13, 2008
Clinical News

Seneca Valley Virus regulatory update

...FDA granted Orphan Drug designation for Neotropix's NTX-010 to treat neuroendocrine cancers. The naturally occurring oncolytic...
...testing for the indication. Neotropix Inc. , Malvern, Pa. Product: Seneca Valley Virus ( NTX-010 ) (formerly SVV-001...
BioCentury | May 22, 2006
Clinical News

Seneca Valley Virus: Phase I started

...with various types of advanced neuroendocrine cancers. Neotropix Inc. , Malvern, Penn. Product: Seneca Valley Virus ( SVV-001...
BioCentury | Dec 20, 2004
Finance

Ebb & Flow

...a series A round, enough to carry the company through Phase I/II trials of its SVV-001...
BioCentury | Dec 13, 2004
Financial News

Neotropix raises $10 million

...Milestone Medica. The company said the financing should carry it through Phase I/II trials of SVV-001...
Items per page:
1 - 10 of 10